Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
1 Apr 24
DEF 14A
Definitive proxy
1 Apr 24
S-8
Registration of securities for employees
27 Mar 24
8-K
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023
27 Mar 24
10-K
2023 FY
Annual report
27 Mar 24
PRE 14A
Preliminary proxy
22 Mar 24
8-K
Regulation FD Disclosure
1 Mar 24
8-K
Entry into a Material Definitive Agreement
2 Jan 24
8-K
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2023
3 Nov 23
10-Q
2023 Q3
Quarterly report
3 Nov 23
8-K
GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2023
2 Aug 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
22 May 23
8-K
GlycoMimetics Reports Highlights and Financial Results for First Quarter 2023
3 May 23
10-Q
2023 Q1
Quarterly report
3 May 23
8-K
Entry into a Material Definitive Agreement
21 Apr 23
ARS
2022 FY
Annual report to shareholders
21 Apr 23
DEF 14A
Definitive proxy
21 Apr 23
S-8
Registration of securities for employees
29 Mar 23
8-K
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2022
29 Mar 23
10-K
2022 FY
Annual report
29 Mar 23
8-K
Regulation FD Disclosure
10 Mar 23
8-K
Regulation FD Disclosure
2 Mar 23
8-K
Departure of Directors or Certain Officers
21 Feb 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
8-K
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2022
9 Nov 22
8-K
Regulation FD Disclosure
4 Oct 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
8-K
GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2022
3 Aug 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3 Jun 22
8-K
Departure of Directors or Certain Officers
20 May 22
424B5
Prospectus supplement for primary offering
28 Apr 22
10-Q
2022 Q1
Quarterly report
28 Apr 22
8-K
GlycoMimetics Reports Highlights and Financial Results
28 Apr 22
EFFECT
Notice of effectiveness
25 Apr 22
CORRESP
Correspondence with SEC
20 Apr 22
DEF 14A
Definitive proxy
11 Apr 22
UPLOAD
Letter from SEC
10 Mar 22
S-3
Shelf registration
4 Mar 22
S-8
Registration of securities for employees
3 Mar 22
Latest ownership filings
4
DANIEL M JUNIUS
2 Apr 24
4
Rachel K. King
2 Apr 24
4
Mark Alan Goldberg
2 Apr 24
SC 13D/A
NEW ENTERPRISE ASSOCIATES 10 L P
29 Feb 24
SC 13D/A
NEW ENTERPRISE ASSOCIATES 10 L P
12 Feb 24
SC 13G/A
Artal International S.C.A.
9 Feb 24
SC 13G/A
BIOTECHNOLOGY VALUE FUND L P
29 Jan 24
4
Bruce S Johnson
17 Jan 24
4
Harout Semerjian
17 Jan 24
4
Edwin Rock
17 Jan 24
4
Chinmaya Rath
17 Jan 24
4
Brian M. Hahn
17 Jan 24
4
Patricia S Andrews
2 Jan 24
4
Rachel K. King
2 Jan 24
4
Mark Alan Goldberg
2 Jan 24
4
Mark Alan Goldberg
3 Oct 23
4
Patricia S Andrews
3 Oct 23
4
Rachel K. King
3 Oct 23
4
Edwin Rock
25 Sep 23
4
Scott Koenig
2 Jun 23
4
Rachel K. King
22 May 23
4
DANIEL M JUNIUS
22 May 23
4
Scott Koenig
22 May 23
4
Mark Alan Goldberg
22 May 23
4
TIMOTHY R PEARSON
22 May 23
4
Patricia S Andrews
22 May 23
4
Scott Thomas Jackson
22 May 23
4
Brian M. Hahn
18 May 23
144
Notice of proposed sale of securities
17 May 23
4
DANIEL M JUNIUS
11 May 23
4
Bruce S Johnson
9 May 23
3
Chinmaya Rath
31 Mar 23
3
Bruce S Johnson
31 Mar 23
4
International S.C.A. Artal
28 Feb 23
4
International S.C.A. Artal
23 Feb 23
4
International S.C.A. Artal
17 Feb 23
4
International S.C.A. Artal
13 Feb 23
3
International S.C.A. Artal
13 Feb 23
SC 13G
Artal International S.C.A.
13 Feb 23
SC 13D/A
NEW ENTERPRISE ASSOCIATES 10 L P
10 Feb 23